Skip to main content

Rothblatt Martine A's Form 4 filing

United Therapeutics Corp (UTHR) · filed Aug 13, 2024

Accession no.
0001415889-24-021168
Filed
Aug 13, 2024
Trade date
Aug 9-12, 2024
Filing delay
4 days
Rule 10b5-1 plan
Checked

This filing lists 12 non-derivative transactions and 2 derivative transactions. Open-market sales total $2.39M. It was filed 4 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Rothblatt Martine ACIK 0001106578Director, Officer (Chairperson & CEO)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Aug 9, 2024Common StockMOption exerciseAcquired+3,600$129.49+$466,1643,730Direct
Aug 9, 2024Common StockSSaleDisposed−1,052$329.82F2−$346,970.642,678Direct
Aug 9, 2024Common StockSSaleDisposed−2,218$330.63F3−$733,337.34460Direct
Aug 9, 2024Common StockSSaleDisposed−330$331.54−$109,408.2130Direct
Aug 12, 2024Common StockMOption exerciseAcquired+3,600$129.49+$466,1643,730Direct
Aug 12, 2024Common StockSSaleDisposed−226$328.74F4−$74,295.243,504Direct
Aug 12, 2024Common StockSSaleDisposed−85$330.45F5−$28,088.253,419Direct
Aug 12, 2024Common StockSSaleDisposed−144$332.64F6−$47,900.163,275Direct
Aug 12, 2024Common StockSSaleDisposed−1,370$333.77F7−$457,264.91,905Direct
Aug 12, 2024Common StockSSaleDisposed−834$334.95F8−$279,348.31,071Direct
Aug 12, 2024Common StockSSaleDisposed−858$335.73F9−$288,056.34213Direct
Aug 12, 2024Common StockSSaleDisposed−83$336.86−$27,959.38130Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Aug 9, 2024Common StockMOption exerciseDisposed−3,600$0.00$036,269Direct
Aug 12, 2024Common StockMOption exerciseDisposed−3,600$0.00$032,669Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F2

This transaction was executed in multiple trades at prices ranging from $329.31 to $330.15. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Referenced by the price of 1 transaction in Table I.

F3

This transaction was executed in multiple trades at prices ranging from $330.35 to $331.13. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Referenced by the price of 1 transaction in Table I.

F4

This transaction was executed in multiple trades at prices ranging from $328.63 to $329.21. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Referenced by the price of 1 transaction in Table I.

F5

This transaction was executed in multiple trades at prices ranging from $329.82 to $330.46. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Referenced by the price of 1 transaction in Table I.

F6

This transaction was executed in multiple trades at prices ranging from $332.415 to $333.20. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Referenced by the price of 1 transaction in Table I.

F7

This transaction was executed in multiple trades at prices ranging from $333.42 to $334.35. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Referenced by the price of 1 transaction in Table I.

F8

This transaction was executed in multiple trades at prices ranging from $334.495 to $335.11. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Referenced by the price of 1 transaction in Table I.

F9

This transaction was executed in multiple trades at prices ranging from $335.54 to $336.46. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Referenced by the price of 1 transaction in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)